Latest Insider Transactions at Fulcrum Therapeutics, Inc. (FULC)
This section provides a real-time view of insider transactions for Fulcrum Therapeutics, Inc. (FULC). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Fulcrum Therapeutics, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Fulcrum Therapeutics, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 22
2021
|
Peter G. Thomson VP Finance & Accounting |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+19.83%
|
$35,000
$7.84 P/Share
|
|
Feb 16
2021
|
Robert J Gould |
SELL
Open market or private sale
|
Direct |
8,215
-0.78%
|
$115,010
$14.38 P/Share
|
|
Jan 21
2021
|
Peter G. Thomson VP Finance & Accounting |
SELL
Open market or private sale
|
Direct |
6,607
-30.28%
|
$92,498
$14.0 P/Share
|
|
Jan 20
2021
|
Robert J Gould |
SELL
Open market or private sale
|
Direct |
10,000
-1.87%
|
$120,000
$12.08 P/Share
|
|
Jul 22
2019
|
Glaxosmithkline PLC |
BUY
Conversion of derivative security
|
Indirect |
1,785,714
+50.0%
|
-
|
|
Jul 22
2019
|
Sanofi > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
93,750
+14.38%
|
$1,500,000
$16.0 P/Share
|
|
Jul 22
2019
|
Sanofi > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
464,285
+50.0%
|
-
|
|
Jul 22
2019
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
140,000
+6.65%
|
$2,100,000
$15.0 P/Share
|
|
Jul 22
2019
|
Casdin Capital, LLC > 10% Shareholder |
BUY
Conversion of derivative security
|
Indirect |
464,285
+50.0%
|
-
|
|
Jul 22
2019
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
81,250
+3.35%
|
$1,300,000
$16.0 P/Share
|
|
Jul 22
2019
|
Third Rock Ventures Iv, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
2,261,904
+50.0%
|
-
|
|
Jul 22
2019
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
81,250
+1.34%
|
$1,300,000
$16.0 P/Share
|
|
Jul 22
2019
|
Third Rock Ventures Iii, L.P. > 10% Shareholder |
BUY
Conversion of derivative security
|
Direct |
5,595,238
+48.76%
|
-
|